text: <unk>  is an antiparkinson agent.
  Its mechanism of action is not well characterized. It is believed to be an NMDA receptor antagonist, however, promoting the synthesis of dopamine.
  Because it provides additional benefits relative to existing treatments, it probably does not precisely mimic the mechanism of an existing known treatment.
option_0: Budipine
option_1: Lercanidipine
option_2: Manidipine
option_3: Lacidipine
option_4: Benidipine
option_5: Clevidipine
option_6: Bamipine
option_7: Nimodipine